POINT BIOPHARMA GLOBAL INC NASDAQ:PNT POINT Biopharma Global Inc. is a globally focused radiopharmaceutical company building a platform for the clinical development and commercialization of radioligands that fight cancer. POINT Biopharma Global Inc. is combining a portfolio of best-in-class radiopharmaceutical assets, a seasoned management team, expertise in radioisotopes such as Actinium-225 (Ac-225) and Lutetium-177 (Lu-177), and industry-leading manufacturing capabilities and supply chain to revolutionize theragnostic drug development and radioligand commercialization. On Dec. 27, 2023, Lilly Completes Acquisition of POINT Biopharma.

Location: | Website: www.pointbiopharma.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing